Animals were deeply anesthetized, killed, and perfused with PBS.
Eyes were enucleated and cleaned of all muscle and connective tissue,
leaving only the globe with some conjunctival tissue and approximately
1 mm of optic nerve. Eyes were immersed in OCT compound (Tissue-Tek;
VWR Scientific, Houston, TX), snap frozen on dry ice, and sectioned on
a semiautomatic cryostat (Microm HM505E; Zeiss, Houston, TX). Serial
sections were collected on consecutive, coated slides (Superfrost/Plus;
Fisher Scientific, Pittsburgh, PA). Monoclonal antibody to an MCMV
early gene product, pp56, was precipitated from the supernatant of
hybridoma cell line 25G11 (a gift of John Shanley, Department of
Medicine, University of Connecticut Health Center, Farmington) by
ammonium sulfate,
27 purified by protein G chromatography
(Gibco, Grand Island, NY), and biotinylated using the EZ sulfonolink
system (Sulfo-NHS-LC-Biotin; Pierce, Rockford, IL) according to the
manufacturer’s instructions. The same method was used for
biotinylation of anti-CD4 (from the GK1.5 hybridoma) and anti-CD8 (from
the 2.43 hybridoma) antibodies. For TdT-dUTP terminal nick-end labeling
(TUNEL), frozen sections were brought to room temperature and fixed in
0.5% glutaraldehyde in phosphate buffered saline (PBS). After washing
in PBS, sections were digested in proteinase K (40 μg/ml; Sigma
Chemical, St. Louis, MO) for 15 minutes. Slides were treated for
endogenous peroxidase by incubation in 0.3%
H
2O
2 for 20 minutes and
then incubated with 15 U/ml terminal deoxynucleotidyl transferase (TdT;
Gibco) and 10 nM/ml biotin-16-dUTP (Boehringer Mannheim, Indianapolis,
IN). Immunohistochemistry and TUNEL assays were conducted using the ABC
streptavidin-horseradish peroxidase kit (Vector, Burlingame, CA) and
developed using DAB (Sigma). All slides were counterstained with methyl
green dye.